An Open Label Study of FT218 in Subjects With Narcolepsy

NCT04451668 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

Narcolepsy
Cataplexy
Excessive Daytime Somnolence
Sleep Disorder
Sleep Disturbance
Sleep Wake Disorders

Interventions

DRUG: FT218

Sponsor

Avadel